RADX

Radiopharm Theranostics Ltd

• TipRanks·10/05 12:21

  Radiopharm completes EOP2 meeting with FDA for RAD101

• Benzinga·10/05 12:09

  Radiopharm Theranostics Announces Completion Of EOP2 Meeting With FDA Regarding RAD101, Investigational Radiopharmaceutical Imaging Agent For Detection Of Brain Metastases

• Benzinga·09/14 21:06

  12 Health Care Stocks Moving In Monday's After-Market Session

• NASDAQ·09/14 15:07

  Radiopharm Selected For Late-Breaking Presentation Of Positive RAD101 Phase 2b Data; Stock Up

• Benzinga·09/14 12:03

  Radiopharm Says Data From Interim Analysis Of Phase 2b Imaging Clinical Trial Of 18F-RAD101 In Participants With Suspected Recurrent Brain Metastases From Solid Tumors Selected For Presentation At SNO26 Annual Meeting

• TipRanks·09/14 10:27

  Radiopharm Theranostics to Present Positive RAD101 Phase 2b Brain Metastases Data at SNO 2026

• Benzinga·09/11 12:06

  12 Health Care Stocks Moving In Friday's Pre-Market Session

• Benzinga·09/10 12:06

  12 Health Care Stocks Moving In Thursday's Pre-Market Session

• NASDAQ·09/09 12:46

  Radiopharm Theranostics Reports Positive Phase 1 Imaging Data For RAD 301 In Pancreatic Cancer

• TipRanks·09/09 11:16

  Radiopharm announces data from imaging trial of RAD 301

• Benzinga·09/09 11:13

  Radiopharm Theranostics Shares Data From Phase 1 Imaging Trial of RAD 301 In Healthy Volunteers And Subjects With Pancreatic Ductal Adenocarcinoma

• TipRanks·08/28 12:27

  Radiopharm Theranostics Posts Deeper FY26 Loss as R&D Spend Jumps and Cash Reserves Fall

• NASDAQ·08/26 11:41

  Radiopharm Doses First Patient In Second Cohort Of Phase 1/2a RV-01 Trial

• TipRanks·08/26 11:15

  Radiopharm doses first patient in second cohort of RV-01 trial

• Benzinga·08/26 11:09

  Radiopharm Doses First Patient In Second Cohort Of Its First-In-Human Phase 1/2a Clinical Trial Of RV-01 In Patients With B7-H3 Expressing Tumors